Amanote Research
Register
Sign In
9 Enzimatic Inhibitors II
doi 10.1515/spark.84.10
Full Text
Open PDF
Abstract
Available in
full text
Date
January 28, 2019
Authors
Joaquín M. Campos Rosa
M. Encarnación Camacho Quesada
Publisher
De Gruyter
Related search
Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK-9) Inhibitors Induced Liver Injury - A Retrospective Analysis
Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Clinical Research in Cardiology Supplements
Nuclear Medicine
Radiology
Molecular Biology
Structural Biology
Imaging
Medicine
DPP8/9 Inhibitors Are Universal Activators of Functional NLRP1 Alleles
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Physicochemical and Enzimatic Transformations of "Eva" Apples Stored Under Modified Atmosphere
Ciencia e Agrotecnologia
Soil Science
Veterinary
Crop Science
Food Science
Animal Science
Zoology
Agronomy
Structures of Matrix Metalloproteinase - 9 in Complex With Pharmacological Inhibitors
Acta Crystallographica Section A Foundations of Crystallography
Cost Effectiveness of Proprotein Convertase Subtilisin/ Kexin Type 9 (PCSK9) Inhibitors
Cardiovascular Disorders and Medicine
Lipoprotein(a) and Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Affinity-Based Probes Based on Type II Kinase Inhibitors
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry
Reactivities of 9-Phenylxanthylium and 9-Phenylthioxanthylium Salts in Electrophilic and Nucleophilic Reactions. II. Structure of Dinitrated 9-Phenylthioxanthylium Perchlorate
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
